Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide for Decompensation of Heart Failure
NCT05802849Phase 4Completed
- Sponsor
- Samara State Medical University
- Start
- May 2023
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetazolamide in chronic heart failure (CHF), sponsored by Samara State Medical University. Started May 2023; status: completed.
02
Drugs
acetazolamide
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT05802849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05802849.